ALGN
Align Technology Inc
NASDAQ: ALGN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$176.01
-1.34% today
Updated 2026-04-30
Market cap
$12.78B
P/E ratio
29.93
P/S ratio
3.17x
EPS (TTM)
$5.96
Dividend yield
—
52W range
$122 – $208
Volume
1.2M
Align Technology Inc (ALGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
10.20%
Operating margin
22.40%
ROE
10.40%
ROA
6.94%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $206.35M | $-34.96M | 68.61% | -18.19% | -16.94% |
| 2007 | $284.33M | $35.72M | 73.61% | 11.91% | 12.56% |
| 2008 | $303.98M | $79.99M | 74.06% | 5.10% | 26.31% |
| 2009 | $312.33M | $-31.27M | 74.76% | -10.89% | -10.01% |
| 2010 | $387.13M | $74.25M | 78.38% | 26.54% | 19.18% |
| 2011 | $479.74M | $66.72M | 75.31% | 18.84% | 13.91% |
| 2012 | $560.04M | $58.69M | 74.35% | 15.28% | 10.48% |
| 2013 | $660.21M | $64.30M | 75.45% | 14.27% | 9.74% |
| 2014 | $761.65M | $145.83M | 75.95% | 25.42% | 19.15% |
| 2015 | $845.49M | $144.02M | 75.71% | 22.31% | 17.03% |
| 2016 | $1.08B | $189.68M | 75.50% | 23.05% | 17.57% |
| 2017 | $1.47B | $231.42M | 75.81% | 24.00% | 15.71% |
| 2018 | $1.97B | $400.24M | 73.63% | 23.73% | 20.35% |
| 2019 | $2.41B | $442.78M | 72.46% | 22.54% | 18.40% |
| 2020 | $2.47B | $1.78B | 71.33% | 15.66% | 71.84% |
| 2021 | $3.95B | $772.02M | 74.26% | 24.70% | 19.53% |
| 2022 | $3.73B | $361.57M | 70.52% | 17.21% | 9.68% |
| 2023 | $3.86B | $445.05M | 70.08% | 16.66% | 11.52% |
| 2024 | $4.00B | $421.36M | 70.00% | 15.19% | 10.54% |
| 2025 | $4.03B | $410.35M | 68.33% | 15.27% | 10.17% |